Regenerative medicine is the quest to provide biological or hybrid synthetic-biological materials that can enable or facilitate therapeutic interventions , from transfusions and gene therapy to organ replacement. A long-standing goal is to ability to produce human blood cells for transfusion medicine. Among blood cells , platelets , needed for blood coagulation and vascular repair , are an expensive “product” in limited supply. This is due to the collection and processing steps from donated blood , and the fact that platelets cannot be frozen , but also due to the possibility of bacterial or blood-borne pathogen contamination. Can we produce platelets in a “blood factory”? This is recognized as a grand challenge that remains largely elusive. Platelets are produced from the large , polyploidy megakaryocytes (Mks) in the bone marrow and the lung vasculature , under a spectrum of biomechanical forces. I will discuss these forces and show how important they are for producing functional proplatelets and other , small , anuclear particles , which we classify as Mk microparticles (MkMPs). I will show the extraordinary ability of these MkMPs in programming stem and progenitor cells , and discuss their potential as a means for targeted delivery of nucleic acids and proteins. I will also discuss our explorations aiming to understand the mechanisms by which MkMPs act , and will argue for producing and using them for regenerative-medicine applications.
Would you like to access this content?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
You must be logged in to view this content. Log in now.
Purchase Technical Presentation
You must purchase this technical presentation using one of the options below.
If you already purchased this content recently, please click here to refresh the system's record of ownerships.
|Credits||0.5 Use credits|
|List Price||$99.00 Buy now|
|AIChE Members||$69.00 Buy now|
|AIChE Undergraduate Student Members||Free Free access|
|AIChE Graduate Student Members||Free Free access|